PMC:7283670 / 62457-62758
Annnotations
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T580","span":{"begin":11,"end":13},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T581","span":{"begin":210,"end":214},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"}],"text":" 400, all, 18 years and older Treatment Experimental: demdesivir (RDV), 5 days participants will receive continued standard of care therapy together with RDV 200 mg on Day 1 followed by RDV 100 mg on Days 2, 3, 4, and 5\nExperimental: remdesivir, 10 days participants will receive continued standard "}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T159","span":{"begin":236,"end":246},"obj":"Chemical"}],"attributes":[{"id":"A159","pred":"chebi_id","subj":"T159","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"}],"text":" 400, all, 18 years and older Treatment Experimental: demdesivir (RDV), 5 days participants will receive continued standard of care therapy together with RDV 200 mg on Day 1 followed by RDV 100 mg on Days 2, 3, 4, and 5\nExperimental: remdesivir, 10 days participants will receive continued standard "}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1889","span":{"begin":81,"end":93},"obj":"Species"},{"id":"1890","span":{"begin":256,"end":268},"obj":"Species"},{"id":"2063","span":{"begin":236,"end":246},"obj":"Chemical"}],"attributes":[{"id":"A1889","pred":"tao:has_database_id","subj":"1889","obj":"Tax:9606"},{"id":"A1890","pred":"tao:has_database_id","subj":"1890","obj":"Tax:9606"},{"id":"A2063","pred":"tao:has_database_id","subj":"2063","obj":"MESH:C000606551"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" 400, all, 18 years and older Treatment Experimental: demdesivir (RDV), 5 days participants will receive continued standard of care therapy together with RDV 200 mg on Day 1 followed by RDV 100 mg on Days 2, 3, 4, and 5\nExperimental: remdesivir, 10 days participants will receive continued standard "}